Sang-Ha Oh

Prof. Dr. Sang-Ha Oh


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Dermatologic Surgery
Verified
Journal Article
Closed access
SOSang-Ha Oh
Sang-Ha Oh
JLJun Young Lee
Jun Young Lee
YSYoung-Joon Seo
Young-Joon Seo
JLJeung-Hoon Lee
Jeung-Hoon Lee
JYJung D. Yang
Jung D. Yang
BCByung C. Cho
Byung C. Cho

1 November 2016 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
SKSena M.S. Kim
Sena M.S. Kim
MAMoonsang Ahn
Moonsang Ahn
YPYibo M.S. Piao
Yibo M.S. Piao
YHYooseok Ha
Yooseok Ha
DCDae-Kyoung Choi
Dae-Kyoung Choi
SOSang-Ha Oh
Sang-Ha Oh
Background: One of the most serious complications of breast surgery using implants is capsular contracture. Several preventive treatments have been introduced; however, the mechanism of capsule formation has not been resolved completely. The authors previously identified negative effects of botulinum toxin type A on capsule formation, expression of transforming growth factor (TGF)-β1, and differentiation of fibroblasts into myofibroblasts. Thus, the authors investigated how to prevent capsule formation by using botulinum toxin type A, particularly by means of TGF-β1 signaling, in human fibroblasts. Methods: In vitro, cultured human fibroblasts were treated with TGF-β1 and/or botulinum toxin type A. Expression of collagen, matrix metalloproteinase, and Smad was examined by Western blotting. The activation of matrix metalloproteinase was observed by gelatin zymography. In vivo, the effect of botulinum toxin type A on the phosphorylation of Smad2 in silicone-induced capsule formation was evaluated by immunocytochemistry. Results: In vitro, the phosphorylation of Smad2 was inhibited by botulinum toxin type A treatment. The expression levels of collagen types 1 and 3 were inhibited by botulinum toxin type A treatment, whereas those of matrix metalloproteinase-2 and matrix metalloproteinase-9 were enhanced. Gelatin zymography experiments confirmed enhanced matrix metalloproteinase-2 activity in collagen degradation. In vivo, botulinum toxin type A treatment reduced capsule thickness and Smad2 phosphorylation in silicone-induced capsules. Conclusion: This study suggests that botulinum toxin type A plays an important role in the inhibition of capsule formation through the TGF-β/Smad signaling pathway. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.

27 February 2018 in Molecular Brain
Verified
Journal Article
Open access
PDF file
YPYibo Piao
Yibo Piao
DGDoHyeong Gwon
DoHyeong Gwon
DKDong-Wook Kang
Dong-Wook Kang
THTae Woong Hwang
Tae Woong Hwang
NSNARA SHIN
NARA SHIN
DKDong Woon Kim
Dong Woon Kim
Neuropathic pain is a complex, chronic pain state characterized by hyperalgesia, allodynia, and spontaneous pain. Accumulating evidence has indicated that the microglial Toll-like receptor 4 (TLR4) and autophagy are implicated in neurodegenerative diseases, but their relationship and role in neuropathic pain remain unclear. In this study, we examined TLR4 and its association with autophagic activity using a chronic constriction injury (CCI)-induced neuropathic pain model in wild-type (WT) and TLR4-knockout (KO) mice. The mice were assigned into four groups: WT-Contralateral (Contra), WT-Ipsilateral (Ipsi), TLR4 KO-Contra, and TLR4 KO-Ipsi. Behavioral and mechanical allodynia tests and biochemical analysis of spinal cord tissue were conducted following CCI to the sciatic nerve. Compared with the Contra group, mechanical allodynia in both the WT- and TLR4 KO-Ipsi groups was significantly increased, and a marked decrease of allodynia was observed in the TLR4 KO-Ipsi group. Although glial cells were upregulated in the WT-Ipsi group, no significant change was observed in the TLR4 KO groups. Moreover, protein expression and immunoreactive cell regulation of autophagy (Beclin 1, p62) were significantly increased in the neurons, but not microglia, of WT-Ipsi group compared with the WT-Contra group. The level of PINK1, a marker for mitophagy was increased in the neurons of WT, but not in TLR4 KO mice. Together, these results show that TLR4-mediated p62 autophagic impairment plays an important role in the occurrence and development of neuropathic pain. And what is more, microglial TLR4-mediated microglial activation might be indirectly coupled to neuronal autophage.

20 November 2012 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MYMin-Hee Yi
Min-Hee Yi
YLyoung-Ha Lee
young-Ha Lee
JKJoon Won Kang
Joon Won Kang
SKSoo Jin Kim
Soo Jin Kim
SOSang-Ha Oh
Sang-Ha Oh
DKDong Woon Kim
Dong Woon Kim

1 October 2012 in Brain Research
Verified
Journal Article
Closed access
MYMin-Hee Yi
Min-Hee Yi
EZEnji Zhang
Enji Zhang
JKJoon Won Kang
Joon Won Kang
YSYu Na Shin
Yu Na Shin
JBJin Young Byun
Jin Young Byun
DKDong Woon Kim
Dong Woon Kim

7 March 2014 in International Wound Journal
Verified
Journal Article
Closed access
PDF file
SLSang D Lee
Sang D Lee
MYMin‐Hee Yi
Min‐Hee Yi
DKDong Woon Kim
Dong Woon Kim
JLJun Young Lee
Jun Young Lee
YCYoungWoong Choi
YoungWoong Choi
SOSang-Ha Oh
Sang-Ha Oh